Cargando…

Knee osteoarthritis accelerates amyloid beta deposition and neurodegeneration in a mouse model of Alzheimer’s disease

Knee osteoarthritis (OA) is characterized by knee cartilage degeneration and secondary bone hyperplasia, resulting in pain, stiffness, and gait disturbance. The relationship between knee OA and neurodegenerative diseases is still unclear. This study used an Alzheimer’s disease (AD) mouse model to ob...

Descripción completa

Detalles Bibliográficos
Autores principales:	Gupta, Deepak Prasad, Lee, Young-Sun, Choe, Youngshik, Kim, Kun-Tae, Song, Gyun Jee, Hwang, Sun-Chul
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2023
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9809050/ https://www.ncbi.nlm.nih.gov/pubmed/36593507 http://dx.doi.org/10.1186/s13041-022-00986-9

Ejemplares similares

CCR5 deficiency accelerates lipopolysaccharide-induced astrogliosis, amyloid-beta deposit and impaired memory function
por: Hwang, Chul Ju, et al.
Publicado: (2016)

Multimodal neuroimaging study of cerebrovascular disease, amyloid deposition, and neurodegeneration in Alzheimer's disease progression
por: Lao, Patrick J., et al.
Publicado: (2018)

Blood amyloid-β oligomerization associated with neurodegeneration of Alzheimer’s disease
por: Youn, Young Chul, et al.
Publicado: (2019)

Serum albumin and beta-amyloid deposition in the human brain
por: Kim, Jee Wook, et al.
Publicado: (2020)

Association of Hippocampal Subfield Volumes with Amyloid-Beta Deposition in Alzheimer’s Disease
por: Baek, Min Seok, et al.
Publicado: (2022)

Amyloid beta, tau, synaptic, neurodegeneration, and glial biomarkers in the preclinical stage of the Alzheimer's continuum
por: Milà‐Alomà, Marta, et al.
Publicado: (2020)

Activation of Ras-ERK Signaling and GSK-3 by Amyloid Precursor Protein and Amyloid Beta Facilitates Neurodegeneration in Alzheimer’s Disease
por: Kirouac, Lisa, et al.
Publicado: (2017)

Progranulin haploinsufficiency reduces amyloid beta deposition in Alzheimer’s disease model mice
por: Hosokawa, Masato, et al.
Publicado: (2017)

Genetic variability in response to amyloid beta deposition influences Alzheimer’s disease risk
por: Salih, Dervis A, et al.
Publicado: (2019)

Relationship of amyloid beta and neurofibrillary tau deposition in Neurodegeneration in Aging Down Syndrome (NiAD) study at baseline
por: Tudorascu, DL, et al.
Publicado: (2020)

Serum zinc levels and in vivo beta-amyloid deposition in the human brain
por: Kim, Jee Wook, et al.
Publicado: (2021)

Brains from non-Alzheimer’s individuals containing amyloid deposits accelerate Aβ deposition in vivo
por: Duran-Aniotz, Claudia, et al.
Publicado: (2013)

Functional Impairment of Microglia Coincides with Beta-Amyloid Deposition in Mice with Alzheimer-Like Pathology
por: Krabbe, Grietje, et al.
Publicado: (2013)

Validation of a priori candidate Alzheimer’s disease SNPs with brain amyloid-beta deposition
por: Vacher, Michael, et al.
Publicado: (2019)

In the blood: biomarkers for amyloid pathology and neurodegeneration in Alzheimer’s disease
por: Toombs, Jamie, et al.
Publicado: (2020)

Acceleration of Amyloidosis by Inflammation in the Amyloid-Beta Marmoset Monkey Model of Alzheimer’s Disease
por: Philippens, Ingrid H., et al.
Publicado: (2016)

Decreased Deposition of Beta-Amyloid 1-38 and Increased Deposition of Beta-Amyloid 1-42 in Brain Tissue of Presenilin-1 E280A Familial Alzheimer’s Disease Patients
por: Dinkel, Felix, et al.
Publicado: (2020)

Clinical Implications of Amyloid-Beta Accumulation in Occipital Lobes in Alzheimer’s Continuum
por: Hwang, Jihye, et al.
Publicado: (2021)

Plasma amyloid beta levels are associated with cerebral amyloid and tau deposition
por: Risacher, Shannon L., et al.
Publicado: (2019)

Amyloid-beta and Alzheimer’s disease: the role of neprilysin-2 in amyloid-beta clearance
por: Marr, Robert A., et al.
Publicado: (2014)

Don’t Lose Sleep Over Neurodegeneration-It Helps Clear Amyloid Beta
por: McKinley, John, et al.
Publicado: (2013)

Unraveling the Burden of Iron in Neurodegeneration: Intersections with Amyloid Beta Peptide Pathology
por: Uranga, Romina María, et al.
Publicado: (2018)

The relationships between neuroinflammation, beta-amyloid and tau deposition in Alzheimer’s disease: a longitudinal PET study
por: Ismail, Rola, et al.
Publicado: (2020)

Inhalable Thioflavin S for the Detection of Amyloid Beta Deposits in the Retina
por: Barton, Shawn M., et al.
Publicado: (2021)

Amyloid Beta in Aging and Alzheimer’s Disease
por: Sehar, Ujala, et al.
Publicado: (2022)

Accelerated Amyloid Beta Pathogenesis by Bacterial Amyloid FapC
por: Javed, Ibrahim, et al.
Publicado: (2020)

Amyloid Beta-Mediated Hypomethylation of Heme Oxygenase 1 Correlates with Cognitive Impairment in Alzheimer’s Disease
por: Sung, Hye Youn, et al.
Publicado: (2016)

Amyloid-beta Alzheimer targets — protein processing, lipid rafts, and amyloid-beta pores
por: Arbor, Sage C., et al.
Publicado: (2016)

Local and distant relationships between amyloid, tau and neurodegeneration in Alzheimer's Disease
por: Iaccarino, Leonardo, et al.
Publicado: (2017)

Glutaminyl cyclase-mediated toxicity of pyroglutamate-beta amyloid induces striatal neurodegeneration
por: Becker, Andreas, et al.
Publicado: (2013)

The temporal relationships between white matter hyperintensities, neurodegeneration, amyloid beta, and cognition
por: Dadar, Mahsa, et al.
Publicado: (2020)

Neurodegeneration-related beta-amyloid as autocatabolism-attenuator in a micro-in vivo system
por: Balazs, Evelin, et al.
Publicado: (2020)

Comparison of the different isoforms of vitamin e against amyloid beta-induced neurodegeneration
por: ÖZDEMİR, Alp Yiğit, et al.
Publicado: (2022)

Inhibition of REV‐ERBs stimulates microglial amyloid‐beta clearance and reduces amyloid plaque deposition in the 5XFAD mouse model of Alzheimer’s disease
por: Lee, Jiyeon, et al.
Publicado: (2019)

Therapeutic Trem2 activation ameliorates amyloid-beta deposition and improves cognition in the 5XFAD model of amyloid deposition
por: Price, Brittani R., et al.
Publicado: (2020)

Synergistic interaction between APOE and family history of Alzheimer’s disease on cerebral amyloid deposition and glucose metabolism
por: Yi, Dahyun, et al.
Publicado: (2018)

Beta Amyloid Deposition Is Not Associated With Cognitive Impairment in Parkinson's Disease
por: Melzer, Tracy R., et al.
Publicado: (2019)

Abrogation of the Circadian Nuclear Receptor REV-ERBα Exacerbates 6-Hydroxydopamine-Induced Dopaminergic Neurodegeneration
por: Kim, Jeongah, et al.
Publicado: (2018)

Editorial on, “Amyloid-beta clearance in Alzheimer's disease”
por: Marr, Robert A.
Publicado: (2014)

Amyloid Beta and MicroRNAs in Alzheimer’s Disease
por: Amakiri, Nnana, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_uj7j7fadip27tqgoh56rsv041m